Skip to main content
SoftOx Solutions AS logo

SoftOx Solutions AS — Investor Relations & Filings

Ticker · SOFTX ISIN · NO0010811961 LEI · 549300AETMWJS91G4A50 OL Manufacturing
Filings indexed 574 across all filing types
Latest filing 2020-05-06 Regulatory Filings
Country NO Norway
Listing OL SOFTX

About SoftOx Solutions AS

https://soft-ox.com/

SoftOx Solutions AS is a clinical-stage pharmaceutical company that has developed a patented, non-toxic antimicrobial technology. The technology is based on a stabilized formulation of hypochlorous acid (HOCl), an endogenous molecule used by the human immune system to combat pathogens. It is designed to be highly effective against a broad spectrum of bacteria, viruses, and fungi, and to eradicate and prevent biofilm infections. A key feature of the technology is that its mode of action does not induce antimicrobial resistance (AMR). The company's development pipeline focuses on significant health challenges, with a lead candidate, SoftOx Inhalation Solution (SIS), for treating airway infections, as well as other applications in wound care and disinfection.

Recent filings

Filing Released Lang Actions
SoftOx oppdatering på Produksjon
Regulatory Filings Classification · 90% confidence The document is very short (418 characters) and provides a brief operational update from SoftOx Solutions AS regarding the establishment of new production lines with a capacity of 45,000 bottles daily for disinfectants, and plans for an additional line. This is not a formal financial report (like 10-K or IR), nor is it a specific announcement like a dividend, director dealing, or AGM material. It is a general operational update that doesn't fit the highly specific categories like ER, CT, or CAP. Given the nature of a brief, non-financial, operational announcement that doesn't fit other specific codes, the most appropriate fallback category is Regulatory Filings (RNS), which serves as a general announcement category.
2020-05-06 Norwegian
A message from the largest shareholder, Kristian Almås
Major Shareholding Notification Classification · 99% confidence The document is a short statement from a major shareholder, Kristian Almås, clarifying his motives for resigning from the board and explicitly stating his continued confidence by promising not to sell shares until the end of Q2. This is not a formal regulatory filing like a 10-K or an earnings release. It is a personal communication regarding his position and future share intentions, which falls under general shareholder/insider communication. Since there is no specific category for a major shareholder's personal statement on confidence/non-selling intentions, and it is not a Director's Dealing report (which reports actual trades), the most appropriate general category is Regulatory Filings (RNS) as a miscellaneous announcement, or potentially related to Board/Management Information (MANG) due to the board resignation context, but the content is primarily about shareholding intent. Given the focus on shareholding commitment and the short, non-standard nature, RNS is the safest fallback. However, since it directly relates to a director's position and future share activity, it has elements of DIRS or MANG. Since no actual trade is reported, DIRS is incorrect. Since it's not a formal management change announcement, MANG is weak. I will classify it as RNS as a general announcement regarding a major shareholder's position and intent.
2020-04-21 English
News from SoftOx
Board/Management Information Classification · 99% confidence The document explicitly announces changes to the Board of Directors (Kristian Almås stepping down) and the hiring of new personnel to strengthen the Management team (COO, Communication/Business Development, Financial Manager). This content directly aligns with the definition of Board/Management Information.
2020-04-20 English
Nytt fra SoftOx
Board/Management Information Classification · 100% confidence The document text, titled 'Nytt fra SoftOx' (News from SoftOx), explicitly announces changes in the composition of the Board of Directors ('endring I styrets sammensetning meldes') and the addition of new, temporarily hired individuals to the management team (COO, Communication/Business Development, Financial Manager). This content directly relates to changes in senior management and the board structure. According to the definitions, 'Board/Management Information (Code: MANG)' covers the 'Announcement of changes in the company's board of directors or senior management.' The document is a direct announcement of these changes, not a presentation (AGM-R), a full report (10-K/IR), or a proxy statement (PSI). Therefore, MANG is the most appropriate classification.
2020-04-20 Norwegian
Følgende rapporteres fra Primary Insider Hans Petter Grette Director Sales and Marketing i SoftOx Solutions;
Director's Dealing Classification · 99% confidence The document text explicitly reports transactions made by a 'Primary Insider' (Hans Petter Grette, Director Sales and Marketing) involving the sale and option exercise of shares in SoftOx Solutions AS. This type of filing, detailing personal share transactions by company directors and executives, directly corresponds to the definition of a Director's Dealing report.
2020-04-16 Norwegian
The following is reported from Primary Insider Hans Petter Grette Director Sales and Marketing in SoftOx Solutions;
Director's Dealing Classification · 99% confidence The document explicitly reports transactions made by a 'Primary Insider' (Hans Petter Grette, Director Sales and Marketing) involving the sale of company shares and the exercise of options through a partly owned company. This type of filing, detailing personal share transactions by directors and executives, directly corresponds to the definition of 'Director's Dealing'. The relevant code is DIRS.
2020-04-16 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.